Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-15T04:22:22.952Z Has data issue: false hasContentIssue false

QuantiFERON-TB Test for Annual Screening of Healthcare Workers: Not Yet Ready for Prime Time in Low-Prevalence Countries

Published online by Cambridge University Press:  02 January 2015

Manish Joshi*
Affiliation:
Pulmonary and Critical Care Medicine, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas
Thomas Monson
Affiliation:
Infection Control, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas
Gail Woods
Affiliation:
Pathology and Lab Medicine, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas
*
Central Arkansas Veterans Healthcare System, 4300 West 7th Street, 5C 144, Little Rock, AR 72205 (mjoshi@uams.edu)
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2011

References

1. Gandra, S, Scott, WS, Somaraju, V, Wang, H, Wilton, S, Feigenbaum, M. Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers. Infect Control Hosp Epidemiol 2010;31:12791285.CrossRefGoogle ScholarPubMed
2. Joshi, M, Monson, T, Woods, G. Practical experience with the QFT-GIT assay for LTBI annual testing among US health-care workers in a large tertiary Setting. Chest 2010;138:746A.CrossRefGoogle Scholar